As a result, EGFR-specific repebodies exhibited efficient tumor accumulation in a dose-dependent manner and preferential renal clearance, as the primary excretion route for other small-sized proteins (Zahnd et al., 2010; Vazquez-Lombardi et al., 2015). This evidence concerns the gene EGFR and neoplasm.